References
1 Editorʼs Choice – Optimal pharmacological treatment of symptomatic peripheral arterial occlusive disease and evidence of female patient disadvantage: An analysis of health insurance claims data. Eur J Vasc Endovasc Surg. 2020;60:421–9.
2 . Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis. Vasc Med. 2020;25:106–17.
3 Suboptimal control of lipid levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS). J Atheroscler Thromb. 2016;23:567–87.
4 Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery. J Vasc Surg. 2014;59:1615–21.
5 Statins and major adverse limb events in patients with peripheral artery disease: A systematic review and meta-analysis. Thromb Haemost. 2020;120:866–75.
6 Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58:S1–S109.e33.
7 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69:e71–e126.
8 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55:305–68.
9 ESVM Guideline on peripheral arterial disease. VASA. 2019;48(Suppl 102):1–79.
10 . Arzneiverordnungs-Report 2000. 2020. https://doi.org10.1007/978-3-662-62168-4
11 Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J. 2015;36:1012–22.
12 . Long-term effectiveness and safety of initiating statin therapy after index revascularization in patients with peripheral arterial occlusive disease. J Am Heart Assoc. 2021; In Press. https://www.ahajournals.org/doi/full/10.1161/JAHA.120.018338
13 Exploring patient involvement in decision making for vascular procedures. J Vasc Surg. 2015;62:1032–9.
14 . Secondary medical prevention in patients with peripheral arterial disease – prescriptions of vascular surgeons and medical doctors (angiologists) in a multidisciplinary vascular centre. VASA. 2010;39:145–52.
15 Multidisciplinary team decision is rare and decreasing in percutaneous vascular interventions despite positive impact on inhospital outcomes. VASA. 2019;48:262–9.